ClinicalTrials.govpublic full text
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
immune-related adverse events, advanced solid tumor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 373600
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.